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Abstract 13 
Objective:  To compare the effectiveness and efficiency of methods used to identify 14 
and export conference abstracts into a bibliographic management tool. 15 
 16 
Study design and setting:  Case study. The effectiveness and efficiency of methods 17 
to identify and export conference abstracts presented at the American Society of 18 
Hematology (ASH) conference 2016-2018 for a systematic review were evaluated.  19 
 20 
A reference standard handsearch of conference proceedings was compared to: 1) 21 
contacting Blood (the journal who report ASH proceedings); 2) keyword searching; 3) 22 
searching Embase; 4) searching MEDLINE via EndNote; and 5) searching CPCI-S. 23 
Effectiveness was determined by the number of abstracts identified compared with 24 
the reference standard, while efficiency was a comparison between the resources 25 
required to identify and export conference abstracts compared to the reference 26 
standard. 27 
 28 
Results:  604 potentially eligible and 15 confirmed eligible conference abstracts 29 
(abstracts included in the review) were identified by the handsearch. Comparator 2 30 
was the only method to identify all abstracts and it was more efficient than the 31 
reference standard. Comparators 1, and 3-5 missed a number of eligible abstracts.  32 
 33 
Conclusion:  This study raises potentially concerning questions about searching for 34 
conferences’ abstracts by methods other than directly searching the original 35 
 2
conference proceedings. Efficiency of exporting would be improved if journals 36 







Searching for reports of studies presented at a conference is an acknowledged 44 
approach to study identification in systematic reviews (1-6). Guidance suggests that 45 
searching conferences may identify newly emerging studies, or updated findings of 46 
on-going studies, potentially ahead of journal publication (2, 3, 7, 8) and that 47 
identifying and including conference abstracts may help minimise the introduction of 48 
bias into systematic reviews (2, 4, 9). There is some evidence that searching 49 
conferences is an effective method of identifying studies which might be missed by 50 
other search methods and identifying studies that are reported at conferences but 51 
never published (4, 5, 10-13).  52 
 53 
Handsearching has traditionally been the method used to search for reports of 54 
studies presented at conferences (6, 25, 26). Handsearching involves a manual, 55 
page-by-page, examination of the entire contents of relevant journals, conference 56 
proceedings and abstracts (2, 4, 7, 9, 14-16). There is evidence that handsearching 57 
is effective when compared to bibliographic database searching and that 58 
handsearching can identify studies (or study data) which may be missed by other 59 
search methods (4, 5, 7, 13-15, 17-24). Whilst handsearching is known to be an 60 
effective method of study identification, it is resource intensive (5).  61 
 62 
When handsearching conference proceedings presented at the American Society of 63 
Hematology (ASH) conference (2016-2018) for a systematic review (25), 604 reports 64 
of potentially eligible abstracts were identified by a handsearch but there was no 65 
option to export all 604 records to a bibliographic management tool in one export. 66 
Instead, each of the 604 abstracts had to be individually identified and downloaded 67 
one-by-one. This added to the resources required to complete the handsearch of  68 
conference proceedings.  69 
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 70 
The inability to download all of the 604 potentially eligible abstracts at the same time, 71 
as is possible in bibliographic databases (where individual studies or a range of 72 
studies can be selected for export), motivated the question: what is the most efficient 73 
way to export abstracts identified by handsearching conference proceedings into a 74 
bibliographic management tool for further screening? The research team 75 
hypothesised potential alternative methods (henceforth comparators) which could 76 
lead to an efficient and successful export of abstracts into a bibliographic 77 
management tool. This case study reports the evaluation of these comparators 78 
compared to the handsearch. 79 
 80 
It is not a straight-forward evaluation to report. When the comparators were tested, it 81 
became apparent that, for some methods, the identification of abstracts could not be 82 
isolated from the task of exporting abstracts. As such, the research objectives 83 
became broader than the problem of exporting conference abstracts to include a 84 
focus on the effective identification of conference abstracts reported at ASH.  85 
 86 
Study objectives 87 
This case study aims to evaluate the effectiveness and the efficiency of methods to 88 
identify and download eligible conference abstracts reported at ASH 2016-2018 for a 89 
systematic review of intervention effectiveness. The research objectives of this case 90 
study are: 91 
 92 
1. to determine whether there is a more efficient method for downloading eligible 93 
conference abstracts following a handsearch compared to the current technology 94 
(i.e., individually downloading records); 95 
2. to evaluate the effectiveness of comparator methods to identify the same 96 
abstracts found by the reference standard handsearch across two stages of study 97 
identification ('potentially eligible' and 'confirmed eligible'); and 98 
3. to evaluate the efficiency of the various methods across two stages of study 99 





Study design  104 
A case study based on a systematic review is presented (25, 26). This case study 105 
was designed as a comparison between reference standard and comparators. The 106 
details of the reference standard and comparators are set out below alongside the 107 
methods of analysis. 108 
 109 
Data  110 
Data were conference proceedings reported at ASH 2016-2018 published in the 111 
supplement editions of the journal Blood. The editorial team at Blood confirmed that 112 
17,759 conference abstracts were reported at ASH for this period. The reference 113 
standard handsearch identified 604 abstracts as potentially eligible for further 114 
screening and 15 abstracts were confirmed eligible for inclusion in the systematic 115 
review based on PICOS eligibility criteria and on the basis of independent double-116 
screening. The 17,759 total eligible, 604 potentially eligible, and 15 confirmed eligible 117 
abstracts, represent data for this case study. 118 
 119 
The reference standard 120 
The reference standard is a method derived from recommended best practice 121 
guidance. A handsearch of the ASH conference proceedings was undertaken by one 122 
experienced reviewer (CC). The reviewer handsearched the supplement editions of 123 
the 2016-2018 ASH conference proceedings reported in the journal Blood and 124 
available from: http://www.bloodjournal.org/blood/search-125 
results?f_ArticleTypeDisplayName=Meeting+Report  126 
 127 
The reviewer handsearched on screen, page-by-page looking for any abstracts 128 
reporting the interventions reported in Figure 1, or any potential alternative 129 
references to these interventions, or possible mis-spellings (2, 4, 14, 15). Records of 130 
any additional search terms to those recorded in Figure 1 were kept and then a 131 
keyword search was undertaken using the search function on the journal website 132 
(see journal search function below for detail) to cross-check the handsearch in event 133 
of human error.   134 
 135 












Comparator 1: contacting the journal directly to request exports of the identified 140 
records 141 
The editorial team of the journal Blood were contacted by e-mail to ask if they could 142 
download the 604 potentially eligible abstracts from their internal server. This is a 143 
very different comparator method compared to the other four in two ways. First, it 144 
does not include a search aspect and only taps into the 'download/export' aspect of 145 
study retrieval. Secondly, it is probable that this comparator method would have an 146 
all-or-nothing outcome: either the journal staff would send all 604 records, or they 147 
would not send any. Despite these differences, this comparator method was included 148 
because, if successful, the approach represents an efficient way to circumvent the 149 
individual download problem that was the original motivation for this work and 150 
thereby address objective 1. However, because it is fundamentally different to the 151 
other comparator methods, it was evaluated separately.   152 
 153 
Comparator 2: the search function on the journal website 154 
The journal Blood includes a search function where the supplement edition of a 155 
conference can be keyword searched. This keyword search was utilised in the 156 
reference standard, to ensure completeness of the handsearch in the event of 157 
human error, but it represented a way to identify the same 604 potentially eligible 158 
abstracts for export into a bibliographic screening tool.   159 
 160 
The terms in Figure 1 were searched one-by-one and the abstracts that were 161 
identified were downloaded study-by-study to EndNote using the direct export 162 
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function on the journal website. Further detail on this method is presented in the 163 
web-only material.  164 
 165 
Comparator 3: identifying the specific journal in Embase and searching for abstracts 166 
Embase was chosen over the bibliographic database MEDLINE due to its inclusion 167 
of conference proceedings and material (27). The terms for the interventions, and 168 
associated Emtree controlled indexing, were searched in Embase using the Ovid 169 
interface. This search was limited by publication type to conferences in two ways: 170 
 171 
First, controlled indexing and search fields were searched for abstracts indexed by 172 
publication type (line 1 below) and the ASH conference was searched using relevant 173 
field codes, namely: cf = conference information and cg = conference publication 174 
(line 2 below). 175 
  176 
1. exp conference paper/ 177 
2. ash.cf,cg. 178 
3. 1 or 2 179 
 180 
Secondly, the journal Blood was searched for using the journal field code (jn) and the 181 
abstracts returned were combined with a search for conference.af. (af = all fields). 182 
 183 
These two searches were combined using the Boolean connector “OR” so both 184 
approaches to limiting by publication type were included. The full search syntax, 185 
including a search narrative, is presented in web-only material (28),.  186 
 187 
Comparator 4: a search for the journal Blood was made in PubMed in EndNote 188 
The search terms in Figure 1 were searched using the online search function of 189 
EndNote X8. The following search logic was applied: 190 
 191 
Journal – contains – Blood; AND 192 
Year – contains – 2016*; AND 193 
All fields – contains – the intervention terms in Figure 1**. 194 
 195 
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* 2016 was searched first, then 2017 and finally 2018. ** the intervention terms were 196 
searched one at a time. 197 
 198 
Abstracts were visually inspected and manually de-duplicated. Study records which 199 
reported conference proceedings were retained whilst other journal content (i.e. 200 
abstracts not reported at the ASH conference) were deleted. The search strategy is 201 
reported in web-only material.  202 
 203 
Comparator 5: searching a conference proceedings database (CPCI-S) 204 
A search was undertaken in Conference Proceedings Citation Index- Science (CPCI-205 
S), Web of Science (Clarivate Analytics). The search terms in Figure 1 were 206 
searched on the topic search field and search terms for ASH or: (American-Society-207 
of-Hematology) were searched on the conference search field. Searches were 208 
refined to the years 2016, 2017 or 2018. The search strategy is reported in web-only 209 
material.   210 
 211 
Analysis  212 
Outcomes were recorded at two stages in the study identification process: 213 
 214 
(stage 1) 'potentially eligible’ abstracts were identified on the basis of title or 215 
abstracts and the study record was retrieved for further inspection; and 216 
(stage 2) 'confirmed eligible' abstracts were identified on the basis of screening the 217 
abstract to confirm eligibility and inclusion in the systematic review.  218 
 219 
For stage 1, the reference standard handsearch and comparator 2 (journal search 220 
function, see below) were undertaken in the week commencing February 4th, 2018. 221 
Abstracts were identified and individually (i.e. study-by-study) downloaded to 222 
EndNote using the direct export function on the journal website. Google Chrome 223 
(version 76.0.3809.132) was the web browser. Comparators 3-5 were undertaken on 224 
June 20th, 2019. The search details are reported in web-only material.  225 
 226 
For stage 2, the 604 abstracts identified in the reference standard were downloaded 227 
to EndNote and were independently screened by two experienced reviewers (CW 228 
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and AP). A third experienced reviewer (AS) was available in the event of 229 
disagreements.  230 
 231 
Outcome measurement  232 
The following outcomes were recorded for the reference standard and comparator 233 
methods: 234 
 235 
Number of potentially eligible abstracts (stage 1) 236 
The reference standard identified 604 potentially eligible abstracts which were taken 237 
forward for independent double-screening against predetermined inclusion criteria 238 
(25). The number of abstracts identified by each of the comparator methods deemed 239 
potentially eligible by the reference standard were recorded. 240 
 241 
Number of abstracts fulfilling inclusion criteria for the systematic review (stage 2) 242 
The number of abstracts identified from the reference standard as confirmed eligible 243 
was 15. This represents the final point of comparison where the ability of the 244 
comparators to identify these same 15 abstracts is compared.  245 
 246 
Time  247 
Time was recorded using the stopwatch function on an Apple iPhone 6s. Time was 248 
recorded in minutes. 249 
 250 
Cost 251 
Cost was represented as GBP since this study was undertaken in the UK. An 252 
approach similar to Shemilt et al. was followed to identify local unit costs (29). A mid-253 
point Grade 7 cost (spine point 40) was chosen, since this represents the median 254 
pay of the grade of researcher who might usually undertake the work reported. 255 
University College London salaries and on-costs (2018-2019) were used since this 256 
represents the lead author's home institution and this was the year the case study 257 
was undertaken. These costs included salary, direct salary costs (e.g. pension) and 258 
university indirect costs. Similar to Shemilt et al. the costs included ‘London 259 
Weighting’ which is an uplift provided to staff to cover additional costs of London. 260 
The hourly rate used was £31.38.  261 
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 262 
Evaluation metrics 263 
Metrics were calculated at both stage 1 (handsearching of 'potentially eligible’ 264 
abstracts) and stage 2 (screening 'confirmed eligible' abstracts). What constitutes an 265 
effective, efficient or comprehensive literature search is uncertain (30-32). In this 266 
study, the following understandings are used (12, 30).  267 
 268 
Effectiveness 269 
Effectiveness was determined by comparison with the reference standard 270 
handsearch. Two by two tables were created (reported in web only material) and the 271 
following metrics were calculated to compare effectiveness: 272 
 273 
• Recall (proportion of correctly identified abstracts); 274 
• Precision (proportion of correctly identified abstracts out of all studies 275 
retrieved by the comparator); and 276 
• F-Measure (a harmonic mean was used). The F1-measure is the harmonic 277 
mean of precision and recall; it has no specific weighting towards either, but 278 
will generally be closer to the lower of the two. It is the rate of true positives 279 
with respect to the arithmetic mean of TP+FP and TP+FN (the denominators 280 
for precision and recall respectively) (30, 33). 281 
 282 
Efficiency 283 
Efficiency was the comparison in resources between the reference standard 284 
handsearch and comparator methods, this was calculated as follows: 285 
 286 
• Difference in time taken; and 287 




Objective 1 – efficiency of downloading the handsea rch 292 
 293 
The first study objective was to determine whether there is a more efficient method 294 
for exporting potentially eligible abstracts compared to the current technology 295 
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(individually exporting abstracts). Blood’s editorial team were contacted to enquire if 296 
they could send the 604 potentially eligible records to the research team. All other 297 
comparators could not isolate the export element of this objective from the search 298 
element.  299 
 300 
This approach assumed that the journal had superior access to the conference 301 
abstracts than was available through the journal interface. For example, that the 302 
study records and conference abstracts were available in a bibliographic 303 
management tool housed on an internal server. The editorial team were contacted 304 
twice to request data: first to make the request and second to chase for a response 305 
to the initial e-mail. Contacting the journal took approximately five minutes and cost 306 
approximately £2.65.  307 
 308 
The journal could not provide any of the 604 conference abstracts. The editorial 309 
team confirmed that they only had access to abstracts via the journal interface. 310 
Given that no abstracts were acquired this is not a viable option for future 311 
researchers. As such, there is currently no known way to expedite export of ASH 312 
conference proceedings following a handsearch.  313 
 314 
Objective 2 – effectiveness of identifying conferen ce abstracts  315 
 316 
The second objective was to evaluate the effectiveness of four comparators to 317 
identify the same abstracts as the reference standard handsearch across two stages 318 
of study identification. Stage 1: identification of potentially eligible abstracts through 319 
searching and, stage 2: identification of confirmed eligible abstracts through 320 
screening. 321 
 322 
In Table 1, the results for stage 1 of the identification process – identifying the 604 323 
potentially eligible abstracts – are presented. Only comparator 2 (journal search 324 
function) recalled the same 604 abstracts as the reference standard, so it is the most 325 
effective comparator, while the other comparators were less effective, identifying 326 
fewer potentially eligible abstracts overall. Comparator 3 (Embase) and comparator 4 327 
(EndNote) recorded modest differences in precision compared to the handsearch. 328 
Comparator 3 (Embase) identified four duplicates and one study reported in another 329 
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journal, and comparator 4 (EndNote) identified 22 duplicate abstracts due to the 330 
nature of search method.  331 
 332 
Table 2 sets out differences between the reference standard and comparators as it 333 
relates to the identification of the 15 confirmed eligible abstracts. The results for the 334 
reference standard and comparator 2 (journal search function) are identical because 335 
it was the exact same 604 references to be screened for inclusion in the review. No 336 
additional search terms were identified by the handsearch, so no new search terms 337 
were searched for using comparator 2 (journal search function).  338 
 339 
The findings presented in Table 2 show that, for comparators 3-5 (Embase, EndNote 340 
and CPCI-S), the differences in recall for stage 1 (Table 1) latterly impacted recall for 341 
stage 2 (Table 2), since fewer potentially eligible abstracts were identified for 342 
screening overall which included differing numbers of confirmed eligible abstracts. 343 
The number of missed confirmed eligible abstracts varied by comparator: seven 344 
abstracts were missed in comparator 3 (the Embase search); all 15 abstracts were 345 
missed in comparator 4 (the EndNote search); and six abstracts were missed in 346 
comparator 5 (the CPCI-S search). 347 
 348 
These findings indicate that, not only is there no way to expedite export of abstracts 349 
presented at ASH (objective one), but also with the exception of comparator 2 350 
(journal search function), all other comparators missed confirmed eligible abstracts.   351 
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Handsearch 2. Journal search 
function 
3. Embase 4. EndNote 5. Searching CPCI-S 
Total number of abstracts  17,759 604 464 22 201  
(of 17,759) 
Total number of abstracts 
identified as potentially 
relevant 
604 604 463 20 201 
Recall (Sensitivity)  
% 








Precision  (Positive 
Predictive Value) %, (95% 
CI) 
 100  






(99.2, 100) a 
F-Measure  
(95% CI) 
 1.00b  0.87  
(0.8447, 0.8889) c 
0.06 
(0.0368, 0.0878) c 
0.49 
(0.4576, 0.5425) c 
Time taken for stage 1, 
minutes 
689  
(11 hours 48 minutes) 
72  22  20  6  









Table 2: Identifying abstracts which fulfilled inclusion in the systematic review (stage 2) 360 
 Reference standard  Comparators     
Handsearch 2. Journal search 
function 
3. Embase 4. EndNote 5. Searching CPCI-S 










Number of abstracts that 









Number of abstracts that fulfil inclusion criteria based on 15 from reference standard 
Recall (Sensitivity) %   100 
(78.20 to 100.00) 
53.3  
(26.6 to 78.7) 
0  
(0.00 to 21.80) 
60  
(32.29 to 83.66) 
Precision (Positive 
Predictive Value) % 








 0.0485  
(0.0246, 0.0723) a 
0.0331  
(0.0106, 0.0555) a 
0  
(cannot be calculated 
using bootstrap) 
0.0833  
(0.0323, 0.1350) a 
Time taken to screen  at 
stage 2, minutes 
420 
(0.696 per abstract)  
420 
(0.696 per abstract) 
324 
(5 hours 24 minutes) 
13 66 
(1 hour six minutes) 
Cost to screen , GBP £ 219.66 219.66 177.82 6.76 34.32 
361 
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Objective 3 – efficiency of identifying conference abstracts  362 
 363 
The third objective was to evaluate the efficiency of the comparators compared to 364 
the reference standard handsearch. Table 1 demonstrates that comparator 2 (journal 365 
search function) was more efficient compared to the reference standard (72 vs. 689 366 
minutes) and was accordingly cheaper to undertake overall.  367 
 368 
Comparators 3-5 (Embase, EndNote, CPCI-S) were more efficient in both time and 369 
cost when compared to the reference standard, but they all missed confirmed eligible 370 
abstracts. In other words, the efficiency was not simply a function of increased 371 
precision - eligible abstracts were missed alongside the ineligible.  Since the purpose 372 
of the comparators was to identify all 15 confirmed eligible abstracts identified by the 373 
handsearch, comparators 3-5 are deemed ineffective overall. The F-Measure 374 
illustrates the difference between comparators and the harmonised effectiveness 375 
and efficiency findings, further suggesting that comparator 2 (journal search function) 376 
was optimal when compared to the other comparators.  377 
Discussion 378 
 379 
This work was initially conceived to address the question: how does a researcher 380 
efficiently export potentially eligible conference abstracts identified by handsearching 381 
the ASH conference to a bibliographic management tool for screening? The aim was 382 
ultimately revised since the task of identifying abstracts in the comparators could not 383 
be separated from the act of exporting eligible abstracts. The variation in recall 384 
between the reference standard and comparators, and the finding that comparators 385 
3-5 (Embase, EndNote, CPCI-S) missed eligible studies, is the main finding of this 386 
work. This raises some potentially concerning questions about searching for 387 
conference abstracts by methods which do not involve a direct search of conference 388 
proceedings (either by handsearch or keyword searches).  We do not know the 389 
extent to which existing completed reviews may have missed conference abstracts if 390 
they used one of the (potentially sub-optimal) comparators. 391 
 392 
Generalisability of the findings 393 
It is important to highlight the primary limitation of this work. The work presented 394 
here is the evaluation of one individual case study. The findings may not generalise 395 
to other searches in ASH, or other conferences, or in other disciplines. The finding 396 
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that comparator 2 (journal search function) was as effective but more efficient should 397 
be firmly situated in these limitations. The findings are not an argument to 398 
discontinue handsearching in systematic reviews.  399 
 400 
It is anticipated that the findings set out here are specific to the date that the 401 
searching for comparators 3-5 were undertaken. Namely, as more content from ASH 402 
is added to bibliographic databases, a greater number of eligible abstracts would be 403 
identified. Changes in recall and precision in the comparators compared to the 404 
handsearch over time are expected. It is worth noting that many conferences are not 405 
published either separately on-line or in journals: work on how to identify such 406 
studies may be particularly valuable’. 407 
 408 
Efficiency findings 409 
Comparator 2 (journal search function) was simple and easy to use but, without the 410 
ability to select a range of abstracts (as is possible in bibliographic databases), the 411 
interfaces are not ‘user friendly’ for systematic reviews where multiple abstracts are 412 
likely to be downloaded. Most bibliographic database hosts have evolved to meet the 413 
needs of systematic reviewers and most database hosts facilitate complicated 414 
search strategies and the need to download a number of abstracts (34). Whilst the 415 
focus in this case study was on the journal Blood, an informal look at other journals 416 
which report conferences in supplement editions, suggests that the inability to 417 
download a number of abstracts is a common issue. Whilst it is acknowledged that 418 
journals and journal supplements serve a different purpose to bibliographic 419 
databases, increasing the ease with which conferences can be searched (if not 420 
handsearched) would be welcome, and the ability to select a number of abstracts for 421 
downloading rather than individual abstracts, may contribute to improved efficiencies 422 
in downloading conference abstracts and other material.  423 
 424 
As it relates to efficiency, a question may be asked as to why it is necessary to 425 
export potentially eligible abstracts for screening, when the screening could have 426 
been undertaken during handsearching. The simple explanation in this case study 427 
(which is common to other reviews undertaken by the authors) was data 428 
management: so that a clear record of the studies/abstracts identified and processed 429 
in the review was maintained, and the research team had access to the bibliographic 430 
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data from each study for review and citation. As is set out above, the efficiency 431 
questions are to some extent unresolved, and other researchers may be less 432 
interested in the downloading of abstracts reported at conferences, but the 433 
practicable finding in recall between comparators is a key finding of this work.    434 
 435 
Is handsearching still valid? Yes.  436 
The finding that comparator 2 (journal search function) was as effective but more 437 
efficient does not necessarily generalise to other conferences. Comparator 2 may, 438 
however, provide some preliminary evidence that keyword searching might suit the 439 
needs of rapid reviews, which may accept less certainty in the comprehensiveness 440 
of their literature searching in exchange for more efficient searches (35). The risks of 441 
keyword searching compared to handsearching requires further examination.   442 
 443 
The claimed advantages of handsearching have been recently summarised in a 444 
review of supplementary search methods (5). The advantages which relate to this 445 
case study specifically, include: identifying abstracts which have not yet been 446 
published or where there may be a delay between conference presentation and 447 
publication (8); handsearching may identify data which may not be reported in the 448 
abstract, for instance, where relevant data is reported in a figure or table, but not in 449 
the abstract (5, 17); and handsearching (as defined by the Cochrane handbook (4)) 450 
would include searching letters and other content not necessarily available to 451 
keyword searching (5, 14, 15, 19, 21).  452 
 453 
The disadvantages of handsearching were also highlighted (5): namely, that 454 
handsearching is a resource intensive method of study identification (14, 24) and 455 
that handsearching may offer low precision (17, 21). This case study adds further 456 
evidence to these findings,.  Adams et al. also identified that handsearching missed 457 
studies identified by bibliographic databases searching, which they associated with 458 
handsearcher fatigue. As with all searching for systematic reviews, cross-over 459 
between searches may mask the effect of the primacy of one search method over 460 
another and a clear demonstration of ‘true’ effectiveness (6, 17).   461 
 462 
Handsearching remains a valuable method of study identification in systematic 463 
reviews. The findings do, however, underline that the resources required to 464 
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handsearch conferences may limit the practicable use of handsearching to 465 
systematic reviews which require comprehensive literature searches, where 466 
precision in the estimate from statistical meta-analysis is important, and 467 
demonstrable confidence that ‘all’ studies have been identified is required.   468 
 469 
Conference abstract inclusion? 470 
The work reported is based on recommended best practice (2, 36). The findings of 471 
this study support the importance of handsearching the ASH conference since 15 472 
conference abstracts fulfilled inclusion criteria in the systematic review. These 15 473 
abstracts represented 11.1% of includes. Studies reported at conferences represent 474 
a challenge to the practice of undertaking a review (37). Whilst guidance 475 
recommends searching conferences for a comprehensive literature search, guidance 476 
and studies also urge caution when including conference abstracts since the 477 
abstracts themselves rarely provide sufficient data to merit inclusion or permit quality 478 
appraisal (2, 7, 9, 38, 39). Studies have also found differences between findings 479 
presented at conferences and in peer-reviewed publications reported in journals 480 
which raises concerns about the validity of their reporting and the use of this type of 481 
study report in reviews (39-43).  482 
 483 
Conference abstracts can, however, alert researchers to further unique studies, in 484 
particular those which may not otherwise be published, and highlight newly emerging 485 
data for studies which may or may not have already been identified. Whilst there are 486 
issues with the abstracts themselves, the need to identify studies reported at 487 
conference remains an important part of systematic reviews assessing the efficacy of 488 
clinical interventions.     489 
 490 
Limitations  491 
The measure of effectiveness was ultimately the ability of the comparators to identify 492 
the same 15 abstracts which eventually fulfilled inclusion into the systematic review. 493 
The interpretation that it is necessary to identify all 15 abstracts may over-state the 494 
contribution of these 15 (or individual) abstracts to the synthesis and overestimate 495 
the impact of the findings in this study. As is set out above, conference abstracts 496 
present a multitude of problems to the researcher, not least the paucity of data and 497 
the inability to appraise study quality. Determining the value of the 15 confirmed 498 
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eligible abstracts as a way to interpret the findings (beyond the fact that they met 499 
inclusion in the review) is difficult to empirically demonstrate. Where the abstracts 500 
contribute data, repeating the various meta-analyses and including and excluding the 501 
15 conference abstracts as a form of sensitivity analysis, would likely only marginally 502 
alter the confidence intervals and not influence the overall estimate of effectiveness. 503 
Any certainty as to the real value of these abstracts would therefore be speculative 504 
beyond the fact that, in a review of intervention effectiveness, it is important to 505 
identify all relevant studies and study data to minimise bias.  506 
 507 
The handsearch of abstract books was undertaken by only one researcher. Milne 508 
and Thorogood have suggested that independent double-handsearching could 509 
minimise the risk of error (24) but the resources available for this study prohibited 510 
this. It is acknowledged that two researchers independently handsearching abstracts 511 
would have improved the rigour however, the handsearch was cross-checked with a 512 
keyword search, and found the same abstracts.   513 
 514 
Individual Cochrane groups undertake regular handsearching of conferences, the 515 
results of which are loaded into group trials registers and Cochrane’s Central 516 
Register of Controlled Trials (CENTRAL). CENTRAL was searched to check if any of 517 
these 15 abstracts were already indexed. Only four abstracts of the 15 were indexed 518 
(44-47). The data file is reported in web-only material. This search was not included 519 
as a comparator, but it is worth considering, since Cochrane groups are tasked with 520 
handsearching journals to identify reports of studies. The findings of this case study 521 
more generally might also indicate a subtle revision to MECIR conduct standard 28, 522 
namely that databases of conference abstracts may not be a complete resource for 523 
the identification of studies reported at conferences (48).  524 
 525 
We considered the idea of including web-scraping as a comparator. The legal 526 
position as to accessing data in this way and copyright generally were unclear. It 527 
would seem an area for further study if the legal position can be clarified.  528 
 529 
Conclusion 530 
The findings of this case study suggest that, in the case of the ASH conference, the 531 
efficiency of downloading abstracts could be improved if it were possible to identify 532 
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and export a range of potentially eligible abstracts. This finding appears relevant to 533 
other journals which offer conference abstracts in supplement editions online.  534 
 535 
The revised scope of this case study highlights the main finding. Four potential 536 
comparators to a handsearch of conference abstracts for the ASH conference 537 
missed substantial numbers of potentially eligible and confirmed eligible abstracts. 538 
Further research is required to examine if this finding relates to other conferences or 539 
research disciplines. This finding suggests that, for researchers undertaking 540 
searches of the ASH conference, the only reliable method to identify eligible 541 
abstracts was a search of the original supplement editions.  542 
 543 
Only comparator 2 (journal search function) was as effective in identification and 544 
recall as the reference standard handsearch, and it was more efficient. The other 545 
four comparators, whilst more efficient than both the reference standard and 546 
comparator 2, missed eligible abstracts so were deemed less effective. 547 
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Web Only Content 
 
Reference standard 
The handsearch was undertaken on Monday February 4th 2018 using the electronic 
supplement editions of the ASH conference reported in the journal Blood and 
available here: http://www.bloodjournal.org/page/ash-annual-meeting-abstracts   
 
For each year (2016, 2017 and 2018) the table of contents was accessed. The table 




The hyper-link was followed which revealed the abstracts for each individual session. 






















The area highlighted above in the green circle is journal search function. Keywords 
were searched here and then the approach for exporting data as reported for the 
reference standard (above) was followed.  
 
Comparator 3: Embase  
Database: Embase 
Host: Ovid 
Data parameters: 1974 to 2019 June 19 
Date searched: June 20th 2019  
Search purpose: the purpose of this search is to identify studies reported as 
conference abstracts at the conference ASH and which are available in the 
bibliographic database, Embase.  
 
Search syntax Search narrative 
1     pevonedistat/ (428) 
2     Pevonedistat.ti,ab,kw,tn. (96) 
3     MLN4924.ti,ab,kw,tn. (416) 
Lines 1-9 represent the principal search 
terms for the interventions under review. 
Search terms include controlled 
 4
4     decitabine/ (3561) 
5     Decitabine.ti,ab,kw,tn. (3375) 
6     Dacogen.ti,ab,kw,tn. (466) 
7     azacitidine/ (12709) 
8     Azacitidine.ti,ab,kw,tn. (3424) 
9     Vidaza.ti,ab,kw,tn. (704) 
10     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 (16884) 
 
indexing using the Emtree language 
(lines 1, 4, and 7) and free-text search 
terms (lines 2, 3, 5, 6, 8, and 9). The 
free-text search terms are searched on: 
title (ti), abstract (ab), author generated 
key-word (kw) and drug trade name (tn). 
 
The searches for interventions are 
combined at line 10 using the Boolean 
connector OR. This means that all of 
the interventions are searched for.  
 
  
11     exp conference paper/ (792271) 
12     ash.cf,cg. (53694) 
13     11 or 12 (845872) 
14     10 and 13 (1760) 
 
Line 11 is the controlled indexing term 
for studies reported at a conference.  
 
Line 12 focuses specifically on the ash 
conference by searching, ‘conference 
information’ (cf) or ‘conference 
publication’ (cg). Both of these ways of 
limiting to conferences are searched for 
at line 13 before they are combined with 
the intervention search terms set out 
above (lines 1-10). 
15     blood.jn. (97533) 
16     conference.af. (4263018) 
17     15 and 16 (52448) 
18     10 and 17 (1486) 
19     14 or 18 (1761) 
 
Line 15 searches for studies reported in 
the journal (jn) blood. This search is 
limited to studies reporting the term 
‘conference’ in all available search fields 
(af).  
20     limit 19 to yr="2016 - 2018" (468) The search ((popn.) and (limit by 
publication type)) then limited to the 




Comparator 4: EndNote 
Date of search: June 20th 2019 
Search:  
 




See Figure 1 
 
 
 2016 2017 2018  
Pevonedistat 2 0 2   
MLN4924 0 0 2  
Decitabine 2 2 (4 in total 
but 2 were 
2018 records) 
7 (9 in total 
but 2 were 
2018 records) 
 
Dacogen 2 2 (4 in total 
but 2 were 
2018 records) 
7 (9 in total 
but 2 were 
2018 records) 
 
Azacitidine 1 5 (7 in total 
but 2 were 
2018 records) 
10 (12 in total 
but 2 were 
2018 records) 
 
Vidaza 1 5 (7 in total 
but 2 were 
2018 records) 
10 (12 in total 
but 2 were 
2018 records) 
 
Total 8 14 38  
- duplicates 4 9 27  
Total unique 
references  
4 5 11  
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Comparator 5: CPCI-S 
 
Database: Conference Proceedings Citation Index- Science (CPCI-S)  
Host: Web of Science (Clarivate Analytics) 
Data parameters: 1990-Present 




TOPIC: ((Pevonedistat or "MLN4924" or Decitabine or Dacogen or Azacitidine or 
Vidaza)) 















#3 OR #2 




#4 AND #1 





#4 AND #1 
Refined by: PUBLICATION YEARS: ( 2018 OR 2017 OR 2016 ) 
Indexes=CPCI-S Timespan=All years 
 
2x2 tables for calculations 
 
RS v IT 1 (journal search portal) 





Not in correct 
proceedings OR Does 





Study retrieved 604 0 604 
Study not 
retrieved 
0   
Total 604   
Recall (a.k.a. sensitivity): 604/604 = 100% (99.39%, 100%) 
Precision (a.k.a. positive predictive value): 604/604 = 100% (99.2%, 100%) [1-sided 97.5% CI] 
F1-measure: 1.00 (cannot calculate 95% CI in this instance) 
 
RS v IT 2 (Embase)  





Not in correct 
proceedings OR Does 
not contain intervention 
term(s) 
Total 
Embase Study retrieved 463 1 464* 
Study not 
retrieved 
136   
Total 604   
*Excludes 4 duplicate entries 
Recall (a.k.a. sensitivity): 463/604 = 76.7% (73.1%, 80.0%) 
Precision (a.k.a. positive predictive value): 463/464 = 99.8% (98.8%, 100.0%) 
F1-measure: 0.867 (0.8447, 0.8889) 
RS v IT 3 (EndNote) 






Not in correct 
proceedings OR Does 
not contain intervention 
term(s) 
Total 
EndNote Study retrieved 20 22 42 
Study not 
retrieved 
584   
Total 604   
Recall (a.k.a. sensitivity): 20/604 = 3.31% (2.03%, 5.07%) 
Precision (a.k.a. positive predictive value): 20/22 = 90.9% (70.8%, 98.9%) 
F1-measure: 0.062 (0.0368, 0.0878) 
 
RS v IT 4 (CPCI-S) 





Not in correct 
proceedings OR Does 
not contain intervention 
term(s) 
Total 
CPCI-S Study retrieved 201 0 201 
Study not 
retrieved 
403   
Total 604   
Recall (a.k.a. sensitivity): 201/604 = 33.28% (29.53%, 37.19%) 
Precision (a.k.a. positive predictive value): 201/201 = 100% (99.2%, 100%) [1-sided 97.5% CI] 
F1-measure: 0.499 (0.4576, 0.5425) 
RS v IT 5 (contacting the journal for exports of the identified records) 





Not in correct 
proceedings OR Does 
not contain intervention 
term(s) 
Total 
Contacting Blood Study retrieved 0 0 0 
Study not 
retrieved 
604   
Total 604   
Recall (a.k.a. sensitivity): 0/604 = 0.00% (0.00%, 0.61%) 
Precision (a.k.a. positive predictive value): 0/0 = 0  





RS v IT1 (journal search portal) 
  Confirmed eligibility 
Eligible for 
inclusion in review 





Study retrieved 15 589 604 
Study not 
retrieved 
0 17155 17155 
Total 15 17744 17759 
Recall: 15/15 = 100.00% (78.20%, 100.00%) 
Precision: 15/604 = 2.48% (1.40%, 4.06%) 
F1-measure: 0.0485 (0.0246, 0.0723) 
RS v IT2 (Embase) 
  Confirmed eligibility 
Eligible for 
inclusion in review 
Not eligible for 
inclusion 
Total 
Embase Study retrieved 8 455 463* 
Study not 
retrieved 
7   
Total 15   
*Excludes 4 duplicates and 1 study not from correct proceedings 
Recall: 8/15 = 53.5% (26.6%, 78.7%) 
Precision: 8/463 = 1.73% (0.75%, 3.38%) 




RS v IT3 (EndNote) 
  Confirmed eligibility 
Eligible for inclusion in 
review 
Not eligible for 
inclusion 
Total 
EndNote Study retrieved 0 20 20 
Study not 
retrieved 
15   
Total 15   
Recall: 0/15 = 0.00% (0.00%, 21.80%) 
Precision: 0/20 = 0% (0.00%, 16.84%) 
 10
F1-measure: 0.00 (cannot be calculated using bootstrap) 
RS v IT4 (CPCI-S) 




Not eligible for 
inclusion 
Total 
CPCI-S Study retrieved 9 192 201 
Study not 
retrieved 
6   
Total 15   
Recall: 9/15 = 60.00% (32.29%, 83.66%) 
Precision:9/201 = 4.48% (2.07%, 8.33%) 




RS v IT5 (contacting the journal for exports of the identified records) 
  Confirmed eligibility 
Eligible for 
inclusion in review 
Not eligible for 
inclusion 
Total 
Contacting Blood Study 
retrieved 
0 0 0 
Study not 
retrieved 
15   
Total 15   
Recall: 0/15 = 0.00% (0.00%, 21.80%) 










The 15 abstracts of studies fulfilling inclusion in this study and if they are indexed in 
CENTRAL  
 11
Study title Included in 
CENTRAL? 
FINAL results of an phase, multicenter, randomised, controlled 
OPEN LEVEL trial: decitabine therapy in patients with 
myelodysplastic syndromes (49) 
 
yes 
A Randomized Phase II Study of Azacitidine (AZA) Alone or 
with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin 
(IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial (50) 
no 
Long-Term Experience with Hypomethylating Agents in 
Patients with Chronic Myelomonocytic Leukemia (51) 
no 
Preliminary Results from a Phase II Study of the Combination 
of Azacitidine and Pembrolizumab in Patients with Higher-Risk 
Myelodysplastic Syndrome (52) 
no 
Comparison of Two Different Therapeutic Regimens with 
Azacitidine and Lenalidomide (Combined versus Sequential) in 
Higher-Risk Myelodysplastic Syndromes. Update of Long-Term 
Results of a Randomized Phase II Multicenter Study (45) 
yes 
Double Immune Checkpoint Inhibitor Blockade with Nivolumab 
and Ipilimumab with or without Azacitidine in Patients with 
Myelodysplastic Syndrome (MDS)(53) 
no 
A Phase II Study of Nivolumab or Ipilimumab with or without 
Azacitidine for Patients with Myelodysplastic Syndrome (MDS) 
(54) 
no 
Planned Interim Analysis of a Phase 2 Study Evaluating the 
Combination of Pracinostat, a Histone Deacetylase Inhibitor 
(HDACi), and Azacitidine in Patients with High/Very High-Risk 
Myelodysplastic Syndrome (MDS) (55) 
no 
Azacitidine Use in the Real World Does Not Replicate AZA-001 
Results in Higher Risk MDS/Low Blast Count AML: An Audit of 
1101 Patients in the Cancer Care Ontario Registry (56) 
no 
Phase 2 Expansion Study of Oral Rigosertib Combined with 
Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) 
no 
 12
Myelodysplastic Syndromes (MDS): Efficacy and Safety 
Results in HMA Treatment Naïve &amp; Relapsed 
(Rel)/Refractory (Ref) Patients (57) 
Azacitidine and lenalidomide (combined vs sequential 
treatment) in higher-risk myelodysplastic syndromes. long-term 
results of a randomized phase II multicenter study (46) 
yes 
A phase II study evaluating the combination of nivolumab 
(Nivo) or Ipilimumab (Ipi) with azacitidine in pts with previously 
treated or untreated myelodysplastic syndromes (MDS) (47) 
yes 
Myelodysplastic syndromes/myeloproliferative neoplasms 
treated with 5-azacytidine. Results from the hellenic 5-
azacytidine registry (58) 
no 
Azacytidine failure revisited: An appraisal based on real life 
data from the MDS registry of the hellenic myelodysplastic 
syndrome study group (hMDS) (59) 
no 
The outcome of patients with high risk MDS achieving stable 
disease after treatment with 5-azacitidine. A retrospective 
analysis of the hellenic (Greek) MDS study group (60) 
no 
 
 
 
